Home MarketFortis Healthcare Ltd.

Fortis Healthcare Ltd. Stock Info: As on 2018-04-25 15:58:19

Nse

152.65

0.75(0.49%)
Change%
52 Week Range
107.10
6.00
228.95
3.00
Open153.00
Day's Range121.52 - 182.28
Value Traded (in ₹ Cr.) 114.89

Bse

152.65

1.10(0.73%)
Change %
52 Week Range
106.65
6.00
230.90
3.00
Open153.10
Day's Range121.24 - 181.86
Value Traded (in ₹ Cr.) 8.69

Stock Exchange

Category No. Of Shares Share %
ForeignPromoters 0.00 0.00%
IndianPromoters 3,970,870.00 0.77%
Mutual Funds/UTI 23,593,662.00 4.55%
FII 236,678,649.00 45.63%
Employee 0.00 0.00%
Public 82,375,020.00 15.88%
Government 0.00 0.00%
Others 81,994,707.00 15.81%
More

Key Statistics

Valuation Measures
Market Cap / Sales Ratio 14.45
Basic EPS (Rs.) -1.57
Cash EPS -0.92
BVPerShare Excl 82.51
Operating Revenue 12.46
PBDITPerShare 0.43
Dividend 0.00
NPPerShare -1.44
Current Ratio 0.48
Quick Ratio 0.47
PriceToBV 2.18
Earnings -0.01
PBDIT Margin 3.51
PBT Margin -17.67
NP Margin -11.57
Return On Assets -1.44
Retention Ratios 0.00
Parameter Mar-17 (₹ Cr.) Yoy%change
Total Income 814.31
Total Expenses 924.62
EBITDA 22.67
PBT -114.04
PAT -74.70
Net Income -74.70
More
Parameter Sep-17 (₹ Cr.) 6M % change
Total Income 411.53
Total Expenses 373.24
EBITDA 24.55
PBT 3.33
PAT 0.73
Net Income 0.00
More
Total Assets
Total Assets
Parameter Mar-17 (₹ Cr.) Yoy%change
Total share capital 517.73
Net worth 4,271.86
Investments 3,602.67
Total Liability 5,160.96
Total debt 624.87
Net block 384.62
Total Assets 5,160.96
Parameter Mar-17 (₹ Cr.) 6M % change
Total share capital 463.13
Net worth 3,608.27
Investments 2,635.50
Total Liability 4,909.37
Total debt 1,044.54
Net block 349.23
Total Assets 4,909.37
Company Curr Price Prev. Close Change% W's Low/High

Apollo Hospitals Enterprise Ltd.

1088.25 1106.85 -1.68
10751148

Aster DM Healthcare Ltd.

168.65 170.2 -0.91
164.05172.4

Dr. Lal Pathlabs Ltd.

847.6 843 0.55
840860

Healthcare Global Enterprises Ltd.

300.6 301.65 -0.35
300318

Indraprastha Medical Corporation Ltd.

49.3 49.55 -0.5
4950.2

Kovai Medical Center and Hospital Ltd.

641.65 624.85 2.68
629.9649.9

Lotus Eye Hospital and Institute Ltd.

30 29.4 2.04
28.232.5
Company Curr Price Prev. Close Change% W's Low/High

ADS Diagnostic Ltd.

11.34 10.8 0
11.3411.34

Apollo Hospitals Enterprise Ltd.

1091.45 1109.4 -1.62
1077.81147.35

Aspira Pathlab & Diagnostics Ltd.

17.82 16.98 4.95
17.8217.82

Aster DM Healthcare Ltd.

0 0 0
164.5171.7

Birla Pacific Medspa Ltd.

0.28 0.27 0
0.270.28

CDR Health Care Ltd.

7.58 2.6 0
7.227.58

Chennai Meenakshi Multispeciality Hospital Ltd.

24.65 25.9 -4.83
23.6525.95
More
Parameter Mar-17(in ₹ Cr.)
Cash from operating activities 29.13
Cash from investing activities -79.88
Cash from financing activities 47.35
Net change in cash -3.41

Stock Held By Mutual Fund Schemes

Scheme Holding (%)
ICICI Prudential MidCap Fund 2.93%
JM Arbitrage Advantage Fund 1.08%
Reliance Growth Fund 0.46%
Aditya Birla Sun Life Midcap Fund 1.11%
Aditya Birla Sun Life Resurgent India Fund - Series 4 1.08%
ICICI Prudential Value Fund - Series 20 0.06%

Astec Lifesciences board to consider final dividend

Astec LifeSciences, a producer of agrochemicals and pharmaceutical intermediates, on Wednesday said that its board would consider recommendation of Final dividend on the equity shares of the company for the Financial Year ended March 31, 2018. “The Meeting of Board of Directors of the Company is scheduled to be held on May 02, 2018, to consider and approve the Standalone and Consolidated Audited Financial Results for the Quarter and Financial Year ended March 31, 2018,” Astec LifeSciences said in a filing to the Bombay Stock Exchange. Meanwhile, shares of company closed day’s trade at 643.50 apiece, up 4.26 per cent, on the Bombay Stock Exchange on Wednesday.

25-04-2018 17:24

Anmol Ambani enters boards of Reliance Nippon Life AMC, RHF

Anmol Ambani, the eldest son of Reliance group chairman Anil Ambani, has been appointed on the boards of Reliance Nippon Life Asset Management (RNAM) and Reliance Home Finance (RHF), reported PTI. The boards of directors of Reliance Nippon Life Asset Management (RNAM) and Reliance Home Finance (RHF) have appointed Anmol Ambani onto their respective boards, said Reliance Capital, a part of Reliance group, in a statement today. Anmol Ambani, 26, is currently the Executive Director of Reliance Capital, the holding company of the group's financial services businesses. Anmol has effected significant changes to the senior leadership team in the group companies, attracting a string of top talent from reputed companies. This positions us better for future growth, has helped bring in fresh thinking and augurs well for the culture change Anmol is driving across the group,” Anil Dhirubhai Ambani said. Anmol was inducted into the board of Reliance Capital in August 2016. He has played an active role in steering the strategy and performance of the operating companies working closely with their respective CEOs, and in bringing about greater cohesion among group entities, Anil Ambani added further. In a fast-growing economy, the potential for both Reliance Nippon Life Asset Management and Reliance Home Finance is immense... We are capturing these opportunities as our recent financial performance reflects, Anmol Ambani said.

25-04-2018 16:37

PNB to hire detective agencies to locate untraceable borrowers

Fraud-hit Punjab National Bank (PNB) has invited applications for empanelment of detective agencies to locate its untraceable borrowers as it looks to significantly supplement efforts to recover bad loans which surged to Rs 57,519 crore at December end, reported PTI. In its efforts to recover NPAs, the PNB has also resorted to 'Gandhigiri' wherein its staff hope to 'name and shame' defaulting borrowers to recover up to Rs 150 crore worth bad loans every month. The Delhi-headquartered bank has been at the receiving end of the over Rs 13,000 crore fraud involving diamond merchants Nirav Modi and Mehul Choksi. PNB today invited applications to empanel detective agencies with an aim to significantly supplement efforts of the field officials in recovering bank's dues in NPA accounts by utilising services of the detective agencies, it said. Interested parties have been asked to file applications and relevant documents by May 5. All NPA accounts (sub-standard, doubtful and loss category would be allocated to detective agencies for gathering information required by the bank. Services of detectives will be hired to locate the borrower(s)/co-borrower(s)/guarantor(s)/ mortgagor(s), (in/outside India) including their legal heirs who are either untraceable or not available at the addresses given in bank's records. The selected agencies will have to ascertain latest information about defaulters present address, occupation, business, income streams, details of their all assets, among other things. They will also have to find out details of bank accounts maintained by the defaulting borrower/guarantor, including their legal heirs. Agencies will be given a maximum 60 days for submission of report, which may be extended to 90 days in emergent circumstances keeping in view complexity of the case. PNB, which is the country's second largest state-run lender after SBI, had gross non-performing assets (NPAs) of Rs 57,519 crore or 12.11 per cent of gross advances as of December 2017.

25-04-2018 16:34

Toyota starts bookings for Yaris; launch in May

Toyota Kirloskar Motor (TKM) today commenced pre-launch bookings of its upcoming mid-sized sedan Yaris, with introductory prices ranging between Rs 8.75 lakh and Rs 14.07 lakh (ex-showroom), reported PTI. TKM, which is a joint venture between auto major Toyota and Kirloskar group, will launch the vehicle in May. Yaris, which marks TKM's entry into highly competitive mid-sized sedan segment, would compete with the likes of Honda City, Maruti Suzuki Ciaz and Hyundai Verna in the Indian market. Customers can make their bookings with Rs 50,000 at any of the authorised Toyota dealerships across the country with deliveries beginning from next month, TKM said in a statement. The manual transmission variants of the sedan are priced between Rs 8.75 lakh and Rs 12.85 lakh while the automatic trims are tagged between Rs 9.95 lakh and Rs 14.07 lakh. The Yaris comes with a 1.5 litre petrol engine mated to 7-speed CVT (continuous variable transmission) and 6-speed manual transmission options.

25-04-2018 15:42

Rs 10,012 cr aid given to UP in 2017-18: Nabard

Development bank Nabard said it has provided an assistance of Rs 10,012 crore to Uttar Pradeshg during 2017-18 to facilitate overall development with special focus on agricultural credit, reported PTI. This has been achieved through commercial banks, RRBs and cooperatives, infrastructure development through dedicated funds, strengthening of rural financial institutions, women empowerment through Self Help Groups, micro-finance and several other new initiatives, Nabard Chief General Manager A K Panda said in a release. Panda said digital transformation of RFIs and rural enterprises, development plans for Bundelkhand region, crop residue management in western UP and irrigation infrastructure and its command management would be on the priority list of the National Bank for Agriculture and Rural Development (Nabard)for 2018-19. He said the financial assistance extended to the state during 2017-18 included Rs 8,450 crore released to commercial banks, Regional Rural Banks and Cooperative Banks for financing agriculture allied and off farm sectors in the state by way of short and long term refinance support. Sanctions under RIDF loans aggregated Rs 1,706 crore and disbursed amount was Rs 1,500 crore for rural infrastructure projects including Rs 1,050 crore for Kanharirrigation project in Sonbhadra. On Nabard's future road map, Panda said it has projected a ground level credit flow target of Rs 2,37,801 crore for 2018-19 for financing by banks under priority sectors such as agriculture, SMEs and other priority sector in Uttar Pradesh which is 17 per cent higher than the projections of Rs 2,10,910 crore for 2017-18. The focus would be on doubling of farmers income and rural employment generation through skill and enterprise development in cluster mode, he added.

25-04-2018 15:35

Fortis Healthcare - Regulation 30 Update

This is with reference to the letter dated April 24, 2018 from Manipal and TPG proposing a further revised offer for Fortis ('Manipal Revised Offer').
As may be noted, the Manipal Revised Offer (which has been submitted to the stock exchanges) states that Manipal and TPG have given Fortis a one-time waiver from the exclusivity provisions under the Implementation Agreement signed with Manipal and TPG on March 27, 2018 by permitting Fortis with a limited ability to undertake a process by permitting due diligence. The aforementioned statement omits certain key facts, such as conditions of the waiver wherein Manipal and TPG sought to impose additional onerous conditions on the Company over and above those contained in the Implementation Agreement that would limit the ability of Fortis to run a competitive bid process if such conditions were to be accepted.
Please find enclosed the letter as received from Manipal Health Enterprises Private Limited in this regard.

25-Apr-2018 06:38 PM

Fortis Healthcare - Updates

Fortis Healthcare Limited has informed the Exchange regarding ''Regulation 30 Update''.This is with reference to the letter dated April 24, 2018 from Manipal and TPG proposing a further revised offer for Fortis (?Manipal Revised Offer?). As may be noted, the Manipal Revised Offer (which has been submitted to the stock exchanges) states that Manipal and TPG have given Fortis a one-time waiver from the exclusivity provisions under the Implementation Agreement signed with Manipal and TPG on March 27, 2018 by permitting Fortis with a limited ability to undertake a process by permitting due diligence. The aforementioned statement omits certain key facts, such as conditions of the waiver wherein Manipal and TPG sought to impose additional onerous conditions on the Company over and above those contained in the Implementation Agreement that would limit the ability of Fortis to run a competitive bid process if such conditions were to be accepted. Please find enclosed the letter as received from Manipal Health Enterprises Private Limited in this regard.

25-Apr-2018 06:37 PM

Radiant makes binding offer to buy Fortis Mulund hospital for Rs 1,200 cr

KKR-backed Radiant Life Care today made a revised bid for Fortis Healthcare Ltd (FHL) with a binding offer to acquire its Mulund hospital for an enterprise value of Rs 1,200 crore. This is the second revised offer received by Fortis today after Malaysian major IHH Healthcare made a binding offer to infuse Rs 650 crore immediately in the Indian firm as part of an overall proposal to invest Rs 4,000 crore. The company has received a binding offer from Radiant Life Care, FHL said in a regulatory filing. In order to provide immediate liquidity to FHL, we would like to make a binding offer to purchase Fortis Mulund hospital without due diligence and as a going concern at an enterprise value of Rs 1,200 crore as the first step, Radiant said in its revised offer to FHL. The transaction would provide an immediate liquidity of Rs 680 crore to FHL, Radiant said. The KKR-backed firm had earlier offered to acquire at least 26 per cent stake in FHL at Rs 126 per share, excluding its diagnostic business SRL. The company also proposed a demerger of hospitals business of FHL into a new company, excluding FHL's stake in SRL. The revised offers have come two days ahead of a meeting of Fortis Healthcare Ltd (FHL) board to consider recommendation by an expert advisory panel formed to finalise evaluation process of only binding offers. Manipal-TPG combine and Munjals and Burmans were the only two groups that had made binding offers out of total of five suitors in race. Chinese firm Fosun Health Holdings and KKR-backed Radiant Life Care had also made non-binding expression of interests in FHL.

25-Apr-2018 02:04 PM

Fortis Healthcare - Updates

Fortis Healthcare Limited has informed the Exchange regarding ''Update under Regulation 30 of SEBI (Listing Obligations and disclosure Requirements)Regulations, 2015''.This is in continuation to our letter Ref. No. FHL/SEC/STEX/RR/2018-19 dated April 10, 2018whereby, it was informed that the Board of Directors of Fortis Healthcare Limited (?the Company?) has received an unsolicited binding offer, revising the earlier construct of the scheme and/or transaction, from Manipal Health Enterprises Private Limited (?MHEPL?), subject to certain conditions as mentioned in the offer letter.It is hereby informed that the Company today i.e. April 24, 2018, has received a New Revised Proposals, as attached herewith, from MHEPL.We will keep the stock exchanges updated/informed in terms of Regulation 30 of the SEBI(Listing Obligations and Disclosure Requirements) Regulations, 2015.This is for your information and records please. We assure you of our full cooperation at alltimes.You are kindly requested to take the same on record.

24-Apr-2018 11:17 PM

Fortis Healthcare - Updates

Fortis Healthcare Limited has informed the Exchange regarding ''Revised Offer from Radiant''.This is in continuation to our letter Ref. No. FHL/SEC/STEX/RR/2018-19 dated April 19, 2018 whereby, it was informed that the Board of Directors of Fortis Healthcare Limited (?the Company?) has received an unsolicited non-binding expression of interest from Radiant Life Care Private Limited (?Radiant?) with a proposal for making investment and/or re-structuring the Company subject to certain conditions as mentioned in the offer letter. It is hereby informed that the Company today i.e. April 24, 2018, has received a Revised Offer, as attached herewith, from Radiant.We will keep the stock exchanges updated/informed in terms of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.This is for your information and records please. We assure you of our full cooperation at all times.You are kindly requested to take the same on record.

24-Apr-2018 09:29 PM

Fortis Healthcare - Regulation 30 Update

This is with reference to the letter dated April 24, 2018 from Manipal and TPG proposing a further revised offer for Fortis ('Manipal Revised Offer').
As may be noted, the Manipal Revised Offer (which has been submitted to the stock exchanges) states that Manipal and TPG have given Fortis a one-time waiver from the exclusivity provisions under the Implementation Agreement signed with Manipal and TPG on March 27, 2018 by permitting Fortis with a limited ability to undertake a process by permitting due diligence. The aforementioned statement omits certain key facts, such as conditions of the waiver wherein Manipal and TPG sought to impose additional onerous conditions on the Company over and above those contained in the Implementation Agreement that would limit the ability of Fortis to run a competitive bid process if such conditions were to be accepted.
Please find enclosed the letter as received from Manipal Health Enterprises Private Limited in this regard.

25-Apr-2018 06:38 PM

Fortis Healthcare - Regulation 30 Update

This is in continuation to our letter Ref. No. FHL/SEC/STEX/RR/2018-19 dated April 13 and April 18, 2018 whereby, it was informed that the Board of Directors of Fortis Healthcare Limited ('the Company') has received an unsolicited binding offer from IHH Healthcare Berhand ('IHH') with a proposal to invest in the Company.

It is hereby informed that the Company today i.e. April 24, 2018, has received an improved offer, as attached herewith, from IHH to invest directly into the Company.

We will keep the stock exchanges updated/informed in terms of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

This is for your information and records please. We assure you of our full cooperation at all times.

24-Apr-2018 04:06 PM

Fortis Healthcare - Compliance Certificate- Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulat

Pursuant to Regulation 7(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith Compliance Certificate certifying the compliance with the requirement of Regulation 7(2) for the half year ended March 31, 2018.

Kindly acknowledge receipt of the same.

24-Apr-2018 10:40 AM

Corporate Details

About Management

The registered office of the Company was initially situated at 25, Nehru Place, New Delhi 110 019, India. Pursuant to a Board resolution dated September 16, 2003 the registered office was shifted to B- 9, Maharani Bagh, New Delhi 110 065, India. Subsequently, pursuant to Board resolution dated February 10, 2006 the registered office of the Company was shifted to Piccadily House, 275- 276, 4th Floor, Captain Gaur Marg, Srinivas Puri, New Delhi 110 065, India, which is the current Registered Office. Scheme of merger/amalgamation between Fortis Medical Centre Holdings Limited and the Company dated October 7, 2005: The High Court of Delhi, through its order dated October 7, 2005 in respect of the company petition (C.P. No: 240/2005 and 241/2005) approved the scheme of amalgamation/merger between the Company and Fortis Medical Centre Holdings Limited ("FMCHL"), and which at the time of amalgamation was our board controlled subsidiary, with effect from April 1, 2004 ("Scheme"). Salient features of the Scheme: The principal terms of the Scheme, as sanctioned by the High Court of Delhi, are set forth below: The entire undertaking and business, all properties, tangible and intangible assets including trademarks, patents, design, copyrights, investments, approvals, licenses, tax benefits, pending projects, debts, liabilities and obligations, including income tax liabilities accrued or to accrue in FMCHL was transferred to the Company with effect from April 1, 2004. Pursuant to the Scheme, Fortis Hospital, Amritsar was transferred to the Company. However, the transfer of the aforesaid was subject to the existing charges or hypothecation in respect of the assets of FMCHL. All the staff, workmen and employees of FMCHL in employment on the date immediately preceding December 23, 2005 (i.e., the date on which a certified copy of the order of the High Court of Delhi was filed with the RoC) became the employees of the Company without any break or discontinuity in service and on conditions not less favourable than those subsisting at FMCHL. In consideration of the transfer and vesting of the undertaking and the assets and liabilities of FMCHL and in consideration of the mutual covenants agreed to in the Scheme, the Company agreed to allot the Equity Shares to the existing shareholders of FMCHL, in the ratio of 1:4 (i.e., one Equity Share in exchange of every four equity shares of FMCHL of Rs. 10 each). In compliance with the Scheme, the Company allotted 520,000 Equity Shares to the shareholders of erstwhile FMCHL on February 10, 2006. Major Events: Year Event June 2001 Commissioning of Fortis Hospital, Mohali. August 2003 Inauguration and commissioning of Fortis Hospital, Amritsar. October 2003 Executed an agreement with Seth Jessa Ram and Bros Charitable Hospital Trust for the operation and management of Jessa Ram Hospital, New Delhi. August 200 Commissioning of Fortis Hospital, Noida. September 2005 Acquired 90% of the equity share capital of Escorts Heart Institute and Research Centre Limited resulting in the acquisition of EHCL, EHSSIL, EHSSHL and EHRCL. October 2005 Signed an agreement with Jeewan Mala Hospital Private Limited for the operation and maintenance of Jeewan Mala Hospital, New Delhi. January 2006 Signed an agreement with Sunrise Medicare Private Limited for the operation and management of Fortis La Femme, New Delhi, and acquisition of 5% equity interest in Sunrise Medicare Private Limited, with an option to acquire additional equity shares. January 2006 Signed an agreement with Khalil Public Welfare Trust for the operation and maintenance of Khyber Medical Institute, Srinagar. March 2006 Acquired 99.99% of the paid up equity share capital of International Hospital Limited resulting in the acquisition of Fortis Hospital, Noida. March 2006 Acquired 100.00% of the paid up equity share capital of Oscar Bio-Tech Private Limited. 2004 -Fortis inks deal with Jessa Ram Hospital to takeover the management of the hospital 2005 -Fortis Hospital rolls out Golden Age Club -Fortis buys Escorts Heart -Fortis Healthcare signs $33.33m pre-IPO deals The Company was incorporated on February 28, 1996 as Rancare Limited under the Companies Act. Subsequently on June 20, 1996 our name was changed to our present name-Fortis Healthcare Limited. The Company received the certificate of commencement of business on July 1, 1996. 2006 -Fortis Healthcare to buy majority stake in Trehan`s Medicity -Fortis Healthcare signs $33.33m pre-IPO deals 2007 -Fortis HealthWorld has joined hands with US hearing aid maker Starkey for its Audible range and is looking to soon offer dental services at its Health stores too. -Colgate-Palmolive India, the market leader in toothpaste in India, declared the acquisition of three domestic companies in south India recently. The company purchased 75 per cent equity in Advanced Oral Care Products (Goa), Professional Oral Care Products (Goa) and SS Oral Hygiene Products (Hyderabad). -Fortis Healthcare acquires Hiranandani Hospital 2008 -Fortis Healthcare Ltd has informed that the Board of Directors of the Company at its meeting held on January 23, 2008, inter alia, has approved change in registered office of the Company from "Piccadily House, 275-276, 4th Floor, Captain Gaur Marg, Srinivas Puri, New Delhi - 110065" to "Escorts Health Institute And Research Centre, Okhla Road, New Delhi - 110025". 2009 -Fortis completes Wockhardt Hospital Acquisition -Fortis signs $15 mn outsourcing deal with HCL -Fortis Healthcare Ltd Issues Rights in the Ratio of 2:5 2010 - 25% stake in Parkway holdings, Asia's largest private healthcare provider. - "Fortis Healthcare infuses USD 100 Million". - Fortis increases stake in Parkway. - Government of Singapore Investment Corp (GIC) to join hands with Fortis at strategic level. - Fortis Healthcare has entered into a pact with two hospitals in Dubai and Tanzania to set up specialised medical facilities. - Company has announced its foray into Speciality Medical Centres focused on the management of diabetes, metabolic diseases and endocrinology. 2011 - A Memorandum of Understanding has been signed by Fortis Healthcare Ltd with the University of Utah to develop courses for Emergency Medical Technicians. - Through its wholly owned subsidiary, has entered into an agreement with Cauvery Hospital Limited, Mysore, wherein Fortis will set up, operate and manage a Cardiac Centre in the hospital. - The name of Fortis Healthcare Limited shall be changed to Fortis Healthcare (India) Limited w.e.f. April 11, 2011. - "Fortis Healthcare ties up with TotipotentRX to set up Stem Cell Therapy Centres". - Fortis Healthcare (India) Ltd has announced that it will buy 86 per cent stake in Super Religare Laboratories Ltd (SRL) . - Fortis Healt - Fortis announces new hospitals in Hyderabad and Agra. 2012 - "Fortis to get Rs. 3700 Mn Equity infusion in SRL through IFC and NYLIM Jacob Ballas India". - Fortis Healthcare raises around S$510 mn through Singapore IPO. -Company has changed its name from Fortis Healthcare (India) Ltd. to Fortis Healthcare Ltd. 2013 -"Fortis launches its Flagship Hospital, One of the First of its Kind in Asia Bridges the gap for expert talent, trans-disciplinary, quaternary care". -"Fortis to divest stake in Quality Healthcare to Bupa for US$ 355 million Intensifies Focus on Healthcare Delivery in India". 2014 -"Fortis launches state of the art, multi super-specialty hospital in Ludhiana". 2016 -Fortis Healthcare has fully acquired Religare Health Trust Trustee Manager for USD 14.9 million (about Rs 100 crore). -Fortis group gets CCI nod for internal reorganisation. -Fortis Healthcare First in India to Monitor and Publish Clinical Outcomes for Cardiology. -Fortis Healthcare launches National helpline for students and parents to help deal exam stress. 2017 -Fortis Healthcare Acquisition of Hiranandani Healthcare Private Limited,Fortis Healthcare Holdings Private Limited and RHC Holding Private Limited.

Registered Office

Fortis-Escorts Hospital: 2nd Floor, Coronation Hospital, Curzon Road,

,,,      ,

Registrar Details

Karvy Computershare Private Ltd.